The global market for bariatric surgeries is projected to grow from US$ 8,546.66 million in 2022 to US$ 27,647.38 million by 2030, reflecting a compound annual growth rate (CAGR) of 15.8% during the period from 2022 to 2030.
The expansion of the bariatric surgeries market is primarily driven by the rising incidence of obesity and an increasing preference for minimally invasive surgical options. Nevertheless, the growth of this market faces challenges due to stringent regulatory frameworks and heightened safety concerns.
Rising Preference for Minimally Invasive Surgical Techniques in Bariatric Procedures
Over the years, there has been a notable increase in chronic health conditions, which has led to a rise in surgical interventions. Traditional invasive surgeries carry significant risks, including prolonged recovery times and a higher likelihood of complications and infections. To mitigate these risks, healthcare providers are increasingly favoring minimally invasive techniques. These procedures offer numerous benefits, such as reduced recovery times, minimal complications, high success rates, and shorter operation durations. According to North Kansas City Hospital (NKCH), approximately 15 million laparoscopic surgeries are conducted annually in the United States. Furthermore, the rise in minimally invasive surgeries has prompted the introduction of new products and the development of specialized surgical instruments.
The favorable results associated with minimally invasive surgeries have heightened interest in minimally invasive bariatric options, as companies strive to innovate and release advanced surgical products. Currently, various minimally invasive bariatric procedures are performed, including laparoscopic gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic gastric banding. The National Health Institutes reported in 2022 that around 90% of gastric bypass surgeries are now performed laparoscopically, with a mortality rate of just 0.22%, significantly lower than the 0.82% associated with open surgeries. Each surgical option presents its own set of benefits and drawbacks, with the choice largely depending on the patient's medical history and specific needs. Additionally, the growing interest in non-invasive bariatric devices is anticipated to further stimulate market growth. Manufacturers are increasingly focusing on the development of gastric balloons, which can be inserted into the stomach via endoscopic procedures and removed when necessary. These balloons typically have minimal side effects and yield positive results. Consequently, the rise in minimally invasive bariatric surgeries, along with the introduction of specialized instruments and favorable patient outcomes, is propelling the growth of the bariatric surgeries market.
Segment Analysis of the Bariatric Surgeries Market
The bariatric surgeries market is categorized based on type, end user, and geographical region.
In terms of type, the bariatric surgeries market is divided into adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (BPD-DS), and others. In 2022, sleeve gastrectomy accounted for the largest market share, while gastric bypass is projected to exhibit the fastest CAGR from 2022 to 2030. Sleeve gastrectomy involves the vertical division and stapling of the stomach, removing over 85% of its volume to create a banana-shaped pouch that restricts food intake and absorption. This procedure significantly reduces levels of ghrelin, the hormone that stimulates appetite, thereby limiting food consumption. However, sleeve gastrectomy carries risks such as heartburn, stomach ulcers, gastritis, potential injury to surrounding organs during surgery, and vomiting. Additionally, nutritional deficiencies and internal scarring may lead to future bowel obstructions.
By end user, the bariatric surgeries market is segmented into hospitals and ambulatory surgical centers. In 2022, hospitals held a larger share of the market, while ambulatory surgical centers are expected to grow at a faster rate from 2022 to 2030. Ambulatory surgical centers (ASCs) are facilities that enable patients to undergo same-day surgeries, including Roux-en-Y gastric bypass, sleeve gastrectomy, duodenal switch surgery, laparoscopic gastric banding (Lap-Band), and non-surgical gastric balloon procedures. Healthy Life Bariatrics is an accredited ASC that emphasizes cleanliness, safety, and personalized care, while the Atlanta General and Bariatric Surgery Center (AGBSC) is located in Georgia, opposite Emory Hospital.
Geographical Insights into the Bariatric Surgeries Market
Geographically, the global bariatric surgeries market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is expected to dominate the market from 2022 to 2030, with further segmentation into the US, Canada, and Mexico. The growth in this region is driven by the increasing prevalence of obesity, government initiatives aimed at combating obesity, and a rising number of collaborations and partnerships among market players. Additionally, the growing incidence of diabetes is fueling the demand for bariatric surgeries. In the US, the market is primarily driven by the escalating obesity rates and the rising prevalence of diabetes, leading to a significant increase in the demand for bariatric procedures to alleviate the burden of associated chronic diseases.
The Asia Pacific bariatric surgeries market includes China, Japan, India, South Korea, Australia, and other countries in the region. The growth of this market is largely driven by collaborations among companies, the rising incidence of diabetes, and an increasing number of individuals classified as obese. The surge in chronic diseases such as diabetes and heart disease is propelling market growth in India, where the obese population is on the rise. Diabetes is particularly prevalent among individuals with higher body fat percentages, prompting many to seek bariatric surgeries, including minimally invasive options like gastric bands and balloons. According to the International Diabetes Federation (IDF), approximately 74 million people in India were diagnosed with diabetes in 2021, a figure projected to reach 124 million by 2045. This anticipated increase in the diabetic population exacerbates the risk of obesity, thereby driving demand for bariatric surgeries aimed at preventing other chronic health issues such as heart disease and organ dysfunction.
To maintain competitiveness in the market, several key players are implementing organic growth strategies. For example, in September 2022, Allurion introduced its swallowable gastric balloon capsule in India, which is designed for weight loss and is the only medical weight-loss device fully approved by the Central Drugs Standard Control Organisation (CDSCO). In June 2021, Intuitive launched the Robotic-Assisted Surgical Stapler SureForm, featuring Smart Fire technology, which represents the most advanced option available for surgeons performing transections, resections, and anastomoses.
Key sources referenced in the preparation of the bariatric surgeries market report include the World Health Organization (WHO), National Council of Aging (NCOA), American Society for Metabolic and Bariatric Surgery, World Obesity Atlas, Health Canada, International Diabetes Federation (IDF), The National Center for Biotechnology Information (NCBI), and the National Library of Medicine (NLM).